GPR84 agonists might be useful for the treatment of cancer by activating the immune response (immuno-oncology), whereas desensitization of GPR84 by agonists might lead to a functional blockade of the receptor, resulting in anti-inflammatory effects and possibly antiproliferative effects on acute myeloid leukemia [62]. The gene discussed is GPR84; the disease is cancer.